SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
December 8, 1999 Date of Report (Date of earliest event reported):
MEDTECH DIAGNOSTICS, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 33-13110 11-2831380
- ------------------ --------------------- ----------------------
(State or other (Commission File No.) (I.R.S. Employer
Jurisdiction of Identification Number)
Incorporation)
900 Third Avenue, Suite 201, New York, New York 10022
-----------------------------------------------------
(Address of Principal Executive Offices)
(212) 610-2778
----------------------------------------------------
(Registrant's Telephone Number, including area code)
16 East 52nd Street, Suite 501, New York, New York 10022
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant.
(a) Previous independent accountants
(i) On December 8, 1999, MedTech Diagnostics, Inc. dismissed
Grant Thornton LLP as its independent accountants.
(ii) The reports of Grant Thornton LLP on the financial
statements for the past two fiscal years contained no adverse
opinion or disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting
principles, however, the opinions included an explanatory
paragraph stating that there were conditions that raised
substantial doubt about the registrant's ability to continue
as a going concern.
(iii) The Board of Directors of MedTech Diagnostics, Inc.,
participated in and approved the decision to change
independent accountants.
(iv) In connection with its audits for the two most recent
fiscal years and through December 8, 1999, there have been no
disagreements with Grant Thornton LLP on any matter of
accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which
disagreements if not resolved to the satisfaction of Grant
Thornton LLP would have caused them to make a reference
thereto in their report on the financial statements for such
periods.
(v) During the two most recent fiscal years and through
December 8, 1999, there have been no reportable events (as
defined in Regulation S-K Item 304(a)(1)(v)).
(vi) MedTech Diagnostics, Inc. has requested that Grant
Thornton LLP furnish it with a letter addressed to the
Securities and Exchange Commission stating whether or not it
agrees with the above statement. A copy of the letter from
Grant Thornton LLP is attached hereto as Exhibit 16 to this
Form 8-K
(b) New independent accountants.
(i) MedTech Diagnostics, Inc. engaged Kaufman, Rossin & Co. as
its new independent accountants, as of December 8, 1999.
During the two most recent fiscal years and through December
8, 1999, MedTech Diagnostics, Inc. has not consulted Kaufman,
Rossin & Co. regarding the application of accounting
principles to a specified transaction, either completed or
proposed; or the type of audit opinion that might be rendered
on the financial statements of MedTech Diagnostics, Inc., and
either a written report was provided to MedTech Diagnostics,
Inc. or oral advice was provided that Kaufman, Rossin & Co.
concluded was an important factor considered by MedTech
Diagnostics, Inc. in reaching a decision as to the accounting,
auditing, or financial reporting issue.
(ii) During the two most recent fiscal years and through
December 8, 1999, MedTech Diagnostics, Inc. has not consulted
Kaufman, Rossin & Co. regarding any matter that was either the
subject of a disagreement, as that term is defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions
to Item 304 of Regulation S-K, or a reportable event, as that
term is defined in Item 304(a)(1)(iv) of Regulation S-K.
(iii) MedTech Diagnostics, Inc. has requested that Kaufman,
Rossin & Co. furnish it with a letter addressed to the
Securities and Exchange Commission stating whether or not it
agrees with the above statement. A copy of the letter from
Kaufman, Rossin & Co. is attached hereto as Exhibit 16 to this
Form 8-K
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
MedTech Diagnostics, Inc. has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
MedTech Diagnostics, Inc.
(Registrant)
By: /s/ STEVEN N. BRONSON
----------------------------
Steven N. Bronson, Sole Officer
Dated: December 29, 1999
Exhibit 16
Grant Thornton, LLP
December 29, 1999
Securities and Exchange Commission
Washington D.C. 20549
Re: MedTech Diagnostics, inc.
File No. 33-131110
Dear Sir or Madam:
We have read Item 4 of the Form 8-K of MedTech Diagnostics, Inc., dated December
29,1999 and agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ Grant Thornton LLP
GRANT THORNTON LLP
Suite 3501
One Huntington Quadrangle
Melville, New York 11747
<PAGE>
KAUFMAN
ROSSIN &
CO., P.A.
2699 South Bayshore Drive
Miami, Florida 33133-5486
WWW.KRCO.CPA.COM
December 29, 1999
Securities and Exchange Commission
Washington D.C. 20549
Ladies and Gentelmen:
We have been engages as of December 8, 1999, as the independent accountants of
Medtech Diagnostics, Inc. (the "Company", SEC File No. 33-13110), effective with
the fiscal year ended September 30, 1999.
We have been furnished with a copy of the 8-K, dated December 29, 1999. We have
read and agree with the statements made therein concerning our retention and our
prior relationship with the Company.
Very truly yours,
Kaufman, Rossin & Co.
/s/ Gregory M. Levy
Gregory M. Levy, CPA
a Partner
